NCT01094340View on ClinicalTrials.gov

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Alzheimer's Disease
Interventions
DRUG

Thalidomide

fixed dose over 8 clinic visits

Trial Locations (1)

85351

RECRUITING

Banner Sun Health Research Institute, Sun City

Sponsors

Lead Sponsor

Banner Health
All Listed Sponsors
lead

Banner Health

OTHER

NCT01094340 - Thalidomide for Patients With Mild to Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter